Please login to the form below

Not currently logged in
Email:
Password:

ranibizumab

This page shows the latest ranibizumab news and features for those working in and with pharma, biotech and healthcare.

FDA approves Coherus’ Cimerli as biosimilar interchangeable with Lucentis for all five indications

FDA approves Coherus’ Cimerli as biosimilar interchangeable with Lucentis for all five indications

Coherus BioSciences has announced that it has received approval from the US Food and Drug Administration (FDA) for its biosimilar Cimerli (ranibizumab-eqrn) as a biosimilar product interchangeable with Lucentis – ranibizumab ... eight, when compared to

Latest news

More from news
Approximately 17 fully matching, plus 67 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Mednet Group

PMEA Agency of the year 2021. With diversity and inclusion at our core, Mednet Group consists of Attigo CIC and...

Latest intelligence

The communication challenge of helping he next generation to be healthier
As the pressure on the health service increases the health of the next generation is vital for everyone. How do we show positive attitudes and change behaviour while future proofing...
Are we losing sight of what the democratisation of healthcare really looks like?
We have a core responsibility as healthcare communicators to consistently drive for better inclusion, engagement and compliance. What does the ‘democratisation of healthcare’ really look like?...
William Kilgallon
How the Royal Society’s EiR programme can help to drive UK innovation
...